Published in

Springer Nature [academic journals on nature.com], Blood Cancer Journal, 9(8), 2018

DOI: 10.1038/s41408-018-0122-3

Links

Tools

Export citation

Search in Google Scholar

Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib

Journal article published in 2018 by Oliver Ottmann, Giuseppe Saglio, Jane F. Apperley ORCID, Christopher Arthur, Eduardo Bullorsky, Aude Charbonnier, John F. Dipersio, Hagop Kantarjian, Hanna Jean Khoury, Dong-Wook Kim, Diane Healey, Lewis Strauss, Jorge E. Cortes
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO